T/NN
cell/NN
reactivity/NN
to/TO
Sjogren/NN
's/POS
syndrome/NN
related/JJ
antigen/NN
La/NN
(/(
SSB/NN
)/)
./.

OBJECTIVE/NN
./.
=====
Many/JJ
patients/NNS
with/IN
primary/JJ
Sjogren/NN
's/POS
syndrome/NN
(/(
SS/NN
)/)
make/VBP
high/JJ
titer/NN
IgG/NN
autoantibodies/NNS
to/TO
the/DT
La/NN
(/(
SSB/NN
)/)
antigen/NN
,/,
suggesting/VBG
antigen/NN
specific/JJ
T/NN
cell-B/NN
cell/NN
interactions/NNS
./.
=====
T/NN
cell/NN
responses/NNS
to/TO
some/DT
nuclear/JJ
antigens/NNS
,/,
particularly/RB
U1RNP/NN
,/,
have/VBP
been/VBN
detected/VBN
in/IN
patients/NNS
with/IN
systemic/JJ
lupus/NN
erythematosus/NN
(/(
SLE/NN
)/)
and/CC
in/IN
healthy/JJ
subjects/NNS
./.
=====
We/PRP
investigated/VBD
T/NN
cell/NN
reactivity/NN
to/TO
the/DT
autoantigen/NN
SSB/NN
in/IN
patients/NNS
with/IN
SS/NN
and/CC
healthy/JJ
controls/NNS
./.
=====
METHODS/NNS
./.
=====
Using/VBG
the/DT
[3H]thymidine/NN
proliferation/NN
assay/NN
,/,
we/PRP
determined/VBD
reactivity/NN
to/TO
purified/VBN
recombinant/JJ
SSB/NN
(/(
rSSB/NN
)/)
in/IN
20/CD
patients/NNS
with/IN
SS/NN
and/CC
19/CD
controls/NNS
./.
=====
Specificity/NN
was/VBD
determined/VBN
using/VBG
tetanus/NN
toxoid/NN
,/,
endotoxin/NN
,/,
and/CC
3/CD
other/JJ
autoantigens/NNS
(/(
PBC.M2/NN
,/,
Sc170/NN
,/,
and/CC
GAD/NN
)/)
./.
=====
Precursor/NN
frequency/NN
was/VBD
calculated/VBN
by/IN
limiting/VBG
dilution/NN
analysis/NN
./.
=====
HLA/NN
Class/NN
II/CD
dependency/NN
was/VBD
investigated/VBN
using/VBG
anti-Class/JJ
II/CD
monoclonal/JJ
antibodies/NNS
./.
=====
HLA-DR/NN
typing/NN
was/VBD
by/IN
polymerase/NN
chain/NN
reaction/NN
and/CC
sequence/NN
specific/JJ
oligonucleotide/NN
typing/NN
./.
=====
RESULTS/NNS
./.
=====
Six/CD
of/IN
20/CD
patients/NNS
with/IN
SS/NN
and/CC
10/19/CD
controls/NNS
proliferated/VBD
to/TO
La/NN
(/(
rSSB/NN
)/)
./.
=====
Precursor/NN
frequency/NN
of/IN
anti-SSB/JJ
T/NN
cells/NNS
was/VBD
1:77,040/CD
and/CC
1:115,000/CD
in/IN
2/CD
healthy/JJ
subjects/NNS
and/CC
1:230,250/CD
and/CC
1:103,034/CD
in/IN
two/CD
patients/NNS
with/IN
SS/NN
./.
=====
Anti-HLA-DR/NN
abrogated/VBD
proliferation/NN
to/TO
SSB/NN
and/CC
tetanus/NN
toxoid/NN
./.
=====
Thirteen/CD
of/IN
15/CD
patients/NNS
with/IN
SS/NN
and/CC
4/17/CD
controls/NNS
were/VBD
HLA-DR3/NN
positive/JJ
,/,
with/IN
no/DT
apparent/JJ
association/NN
of/IN
HLA-DR3/NN
with/IN
SSB/NN
reactivity/NN
in/IN
controls/NNS
./.
=====
CONCLUSION/NN
./.
=====
Anti-La(SSB)/NN
specific/JJ
T/NN
cells/NNS
occur/VBP
in/IN
a/DT
significant/JJ
proportion/NN
of/IN
controls/NNS
and/CC
in/IN
some/DT
patients/NNS
with/IN
SS/NN
./.
=====
The/DT
function/NN
of/IN
SSB/NN
T/NN
cells/NNS
in/IN
controls/NNS
remains/VBZ
to/TO
be/VB
defined/VBN
./.
=====
They/PRP
may/MD
represent/VB
immunoregulatory/JJ
cells/NNS
,/,
and/CC
further/JJ
analysis/NN
of/IN
these/DT
cells/NNS
,/,
and/CC
a/DT
comparison/NN
to/TO
those/DT
found/VBN
in/IN
patients/NNS
with/IN
SS/NN
,/,
may/MD
elucidate/VB
normal/JJ
immunoregulation/NN
and/CC
the/DT
derangements/NNS
that/WDT
lead/VBP
to/TO
Sjogren/NN
's/POS
syndrome/NN
./.